Valuation: Becton, Dickinson and Company

Market Cap 49.57B 257B 43.65B 41.36B 37.33B 70.37B 4,753B 71.28B 495B 190B 2,430B 186B 182B 7,789B P/E 2026 *
35.1x
P/E 2027 * 19.5x
Enterprise Value 65.45B 339B 57.64B 54.61B 49.3B 92.92B 6,276B 94.12B 653B 251B 3,208B 246B 240B 10,286B EV / Sales 2026 *
3.4x
EV / Sales 2027 * 3.22x
Free-Float
73.18%
Yield 2026 *
2.16%
Yield 2027 * 2.19%
Current month-4.85%
1 month-5.43%
3 months+33.07%
6 months+13.09%
Current year-14.72%
1 week 186.3
Extreme 186.3
186.3
1 month 183.73
Extreme 183.73
197
Current year 139.29
Extreme 139.29
242.96
1 year 139.29
Extreme 139.29
242.96
3 years 139.29
Extreme 139.29
286
5 years 139.29
Extreme 139.29
295
10 years 139.29
Extreme 139.29
295
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Chief Tech/Sci/R&D Officer 56 04/12/2023
Director TitleAgeSince
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Chairman 53 28/04/2021
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 49.57B
-2.10%-4.69%-25.75%+2.04% 175B
-0.92%-4.94%-8.17%+10.12% 111B
-0.90%+0.11%-25.55%+0.78% 107B
+0.69%+0.76%-47.04%-11.84% 75.31B
-2.39%-4.51%-2.54%+66.83% 58.7B
-1.63%-2.19%-2.72%-30.76% 49.57B
+1.53%+4.31%+15.99%+53.87% 49.27B
-2.11%+0.13%-17.19%+19.42% 42.02B
-0.40%-3.62%+29.84%-7.51% 32.69B
Average -0.56%-0.69%-9.24%+11.44% 77.84B
Weighted average by Cap. -0.60%-1.13%-15.60%+8.99%

Financials

2026 *2027 *
Net sales 19.26B 99.77B 16.96B 16.07B 14.51B 27.34B 1,847B 27.7B 192B 73.99B 944B 72.32B 70.75B 3,027B 19.73B 102B 17.38B 16.46B 14.86B 28.01B 1,892B 28.38B 197B 75.8B 967B 74.1B 72.48B 3,101B
Net income 1.44B 7.44B 1.27B 1.2B 1.08B 2.04B 138B 2.07B 14.34B 5.52B 70.42B 5.39B 5.28B 226B 2.34B 12.12B 2.06B 1.95B 1.76B 3.32B 224B 3.36B 23.35B 8.99B 115B 8.78B 8.59B 368B
Net Debt 15.88B 82.28B 13.99B 13.25B 11.96B 22.55B 1,523B 22.84B 159B 61.02B 779B 59.65B 58.35B 2,496B 13.95B 72.27B 12.29B 11.64B 10.51B 19.81B 1,338B 20.06B 139B 53.6B 684B 52.39B 51.25B 2,193B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
29/09/26 R$186.30 0.00% 1
22/09/26 R$186.30 +1.40% 2
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
181.97USD
Average target price
195.67USD
Spread / Average Target
+7.53%

Quarterly revenue - Rate of surprise